
|Articles|April 7, 2023
Pharma USA 2023: Changes to the Medical Affairs Function
Sunil Verma, SVP, Global Head of Oncology, Medical, AstraZeneca discusses how the Medical Affairs role will become more strategic and effective with data.
Advertisement
Sunil Verma, MD, SVP, Global Head of Oncology, Medical, AstraZeneca recently presented at Pharma USA 2023 on the topic, "The beginning of a new Medical, the end of an Affair." In this video, Dr. Verma tells PharmExec about how the role of medical affairs will positively influence patient outcomes and the standard of care with the use of data.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Travere Therapeutics’ Filspari Receives Full FDA Approval
2
How Serious is the Biosimilar Void?
3
Regeneron Enters $2.1 Billion Radiopharma Collaboration with Telix Pharmaceuticals
4
Managing Patient Experience and RWE in Clinical Trials: Q&A with Matt Holms, MB
5




